Hami Industries PLC (DSE:HAMI)

Verve Therapeutics Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Aug 8, 2025	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Market Capitalization	794	196	131	74	68	59
Market Cap Growth	-35.99%	50.00%	77.08%	9.09%	14.29%	-1.28%
Enterprise Value	851	204	142	89	104	140
Last Close Price	103.10	25.46	16.97	9.58	8.79	7.69
PE Ratio	659.97	-	-	-	-	-
PS Ratio	16.34	4.11	2.49	1.70	1.86	1.44
PB Ratio	-	4.39	2.73	1.16	0.95	1.02
P/TBV Ratio	-	4.39	2.73	1.16	0.95	1.02
P/FCF Ratio	-	100.58	30.99	61.65	-	-
P/OCF Ratio	-	100.58	8.78	53.20	-	-
EV/Sales Ratio	17.51	4.27	2.69	2.04	2.87	3.38
EV/EBITDA Ratio	-	33.38	25.89	-	-	-
EV/FCF Ratio	-	104.72	33.52	73.96	-	-
Debt / Equity Ratio	-	0.13	0.16	0.19	0.23	0.71
Debt / EBITDA Ratio	-	0.97	1.44	-	-	-
Debt / FCF Ratio	-	3.04	1.86	10.23	-	-
Asset Turnover	-	0.53	0.56	0.44	0.34	0.34
Inventory Turnover	-	8.03	9.16	7.47	5.28	4.92
Quick Ratio	-	0.04	0.05	0.17	0.28	0.17
Current Ratio	-	0.48	0.46	0.71	1.02	0.57
Return on Equity (ROE)	-	-6.71%	-5.17%	-11.41%	-19.46%	-29.83%
Return on Assets (ROA)	-	-0.92%	-1.29%	-4.04%	-6.50%	-6.33%
Return on Capital (ROIC)	-	-1.58%	-1.83%	-4.83%	-7.53%	-7.26%
Earnings Yield	0.15%	-1.58%	-2.21%	-10.46%	-18.64%	-23.44%
FCF Yield	-	0.99%	3.23%	1.62%	-5.94%	-2.57%
Buyback Yield / Dilution	-1.42%	-	0.44%	-0.41%	0.24%	-0.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.